Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Public ClinicalTrials.gov record NCT01969123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's disease currently receiving stable treatment or previously treated with an acetylcholinesterase inhibitor.
Study identification
- NCT ID
- NCT01969123
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 474 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2013 (Type not available)
- Primary completion
- Jan 2017 (Estimated)
- Completion
- Jan 2017 (Estimated)
- Last update posted
- May 3, 2016
2013 – 2017
United States locations
- U.S. sites
- 44
- U.S. states
- 20
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Encino | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Redding | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Atlantis | Florida | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | Delray Beach | Florida | — | — |
| Not listed | Fort Myers | Florida | — | — |
| Not listed | Lake Worth | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Weston | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Douglasville | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Park Ridge | Illinois | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Chestnut Hill | Massachusetts | — | — |
| Not listed | Plymouth | Massachusetts | — | — |
| Not listed | Flowood | Mississippi | — | — |
| Not listed | Creve Coeur | Missouri | — | — |
| Not listed | Princeton | New Jersey | — | — |
| Not listed | Springfield | New Jersey | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Latham | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
| Not listed | Murray | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Bennington | Vermont | — | — |
| Not listed | Williamsburg | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01969123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2016 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01969123 live on ClinicalTrials.gov.